查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1721440

醫藥合約包裝市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Pharmaceutical Contract Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球醫藥合約包裝市場價值為 171 億美元，預計到 2034 年將以 7.8% 的複合年成長率成長，達到 359 億美元。整個製藥業的快速轉型正在顯著影響藥品的包裝和運送方式。隨著個人化治療需求的不斷成長和生物技術創新的進步，製藥商擴大轉向專業的合約包裝供應商來滿足不斷變化的需求。隨著藥物開發變得更有針對性，小批量生產越來越受到關注，包裝解決方案必須靈活、合規，並且能夠處理多種劑型和敏感配方。

醫藥合約包裝市場 - IMG1

合約包裝合作夥伴透過提供符合不斷變化的監管框架、增強的可追溯性要求和不斷發展的以患者為中心的護理模式的可擴展服務發揮關鍵作用。藥品生產和分銷的全球影響力不斷擴大，進一步凸顯了簡化包裝流程的必要性，以確保國際市場的安全性、品質和監管一致性。數位轉型與自動化和智慧包裝工具相結合，正在提高效率，同時加強整個供應鏈的安全性。隨著永續性成為主要優先事項，公司也在整合環保材料，以在不影響性能的情況下減少對環境的影響。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 171億美元
預測值 359億美元
複合年成長率 7.8%

預計二次包裝領域將大幅成長，到 2034 年預計將達到 143 億美元。序列化需求、防篡改功能和資訊標籤正在推動對先進二次包裝服務的需求成長。智慧包裝形式正在成為一種首選，尤其是對於處方藥和非處方藥，因為它們能夠透過2D碼和數位介面進行即時驗證並增強患者參與度。按照全球綠色包裝計劃，再生紙板、環保油墨和水性塗料正受到越來越多的關注，尤其是在旨在提高永續性和最終用戶可訪問性的二次包裝應用中。

預計到 2034 年，藥品合約包裝領域的塑膠部分將產生 100 億美元的產值。塑膠以其成本效益和出色的阻隔性能而聞名，仍然是各種藥物製劑中的主要材料。然而，日益成長的環境問題正在引導市場轉向可生物分解和可回收的塑膠。作為回應，合約包裝供應商正在開發下一代塑膠解決方案，例如輕質生物基材料和高阻隔生物塑膠，以保持產品完整性並支持永續發展目標。

在嚴格的監管標準和不斷發展的序列化要求的推動下，美國醫藥合約包裝市場在 2024 年創造了 53 億美元的收入。 《藥品供應鏈安全法案》（DSCSA）的實施促進了單位級可追溯性、區塊鏈整合和智慧標籤技術的自動化。生物製劑、基因和細胞療法以及溫度敏感藥物的成長正在推動服務提供者加強冷鏈包裝基礎設施以滿足需求。

全球醫藥合約包裝市場的知名參與者包括 Ameripac、Amcor、Baxter Biopharma Solutions、Adare Pharma Solutions 和 Catalent Pharma Solutions。該公司正在利用自動化、序列化和智慧包裝技術（如 NFC 和 QR）來提高合規性、可追溯性和用戶互動性。與醫藥開發商的早期合作以及對永續材料的重視正在幫助合約包裝商提供客製化的、面向未來的包裝解決方案。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 製藥業蓬勃發展
      • 對生物技術和特種藥物的需求不斷成長
      • 臨床試驗和小批量包裝的增加
      • 對永續包裝的需求不斷增加
      • 更加重視序列化與防偽
    • 產業陷阱與挑戰
      • 初始投資和營運成本高
      • 激烈的競爭和價格壓力
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：依類型，2021-2034

  • 主要趨勢
  • 初級包裝
    • 瓶子和罐子
    • 小瓶
    • 安瓿
    • 泡殼包裝
    • 預充式注射器
    • 其他
  • 二次包裝
  • 三級包裝

第6章：市場估計與預測：依材料，2021-2034

  • 主要趨勢
  • 塑膠
  • 玻璃
  • 紙和紙板
  • 鋁
  • 其他

第7章：市場估計與預測：依形式類型，2021-2034

  • 主要趨勢
  • 口服
  • 注射劑
  • 其他

第8章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Adare Pharma Solutions
  • Amcor
  • Ameripac
  • Baxter Biopharma Solutions
  • Catalent Pharma Solutions
  • Daito Pharmaceutical
  • Gracure Pharmaceutical
  • MJS Packaging
  • Nipro
  • Patheon
  • Pharma Packaging Solutions
  • Schott
  • Sharp
  • Sonic Packaging Industries
  • West Pharmaceutical Services
  • WestRock
  • Zoic Biotech
簡介目錄
Product Code: 13460

The Global Pharmaceutical Contract Packaging Market was valued at USD 17.1 billion in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 35.9 billion by 2034. Rapid transformations across the pharmaceutical sector are significantly influencing the way medications are packaged and delivered. With rising demand for personalized therapies and advancements in biotech innovation, pharmaceutical manufacturers are increasingly turning to specialized contract packaging providers to address evolving needs. As drug development becomes more targeted and small-batch production gains traction, packaging solutions must be agile, compliant, and capable of handling diverse dosage forms and sensitive formulations.

Pharmaceutical Contract Packaging Market - IMG1

Contract packaging partners are playing a pivotal role by offering scalable services that align with shifting regulatory frameworks, heightened traceability demands, and growing patient-centric care models. The expanding global footprint of pharmaceutical production and distribution further underscores the need for streamlined packaging processes that ensure security, quality, and regulatory alignment across international markets. Digital transformation, coupled with automation and smart packaging tools, is elevating efficiency while reinforcing safety throughout the supply chain. As sustainability becomes a major priority, companies are also integrating eco-conscious materials to reduce environmental impact without compromising performance.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$17.1 Billion
Forecast Value$35.9 Billion
CAGR7.8%

The secondary packaging segment is anticipated to witness substantial growth, with expectations to reach USD 14.3 billion by 2034. Serialization mandates, tamper-proof features, and informative labeling are fueling the rise in demand for advanced secondary packaging services. Smart packaging formats are becoming a preferred choice, especially for prescription and over-the-counter medications, as they enable real-time verification and enhanced patient engagement through QR codes and digital interfaces. In line with global green packaging initiatives, recycled cartonboard, eco-friendly inks, and water-based coatings are gaining traction, especially in secondary packaging applications designed for improved sustainability and end-user accessibility.

The plastic segment in the pharmaceutical contract packaging space is projected to generate USD 10 billion by 2034. Known for its cost efficiency and excellent barrier properties, plastic remains a dominant material across a wide range of drug formulations. However, increasing environmental concerns are steering the market toward biodegradable and recyclable plastics. In response, contract packaging providers are developing next-generation plastic solutions, such as lightweight bio-based materials and high-barrier bioplastics that maintain product integrity while supporting sustainability goals.

United States Pharmaceutical Contract Packaging Market generated USD 5.3 billion in 2024, driven by stringent regulatory standards and evolving serialization requirements. The implementation of the Drug Supply Chain Security Act (DSCSA) has encouraged unit-level traceability, blockchain integration, and automation of smart labeling technologies. Growth in biologics, gene and cell therapies, and temperature-sensitive drugs is pushing service providers to enhance cold chain packaging infrastructure to meet demand.

Notable players in the Global Pharmaceutical Contract Packaging Market include Ameripac, Amcor, Baxter Biopharma Solutions, Adare Pharma Solutions, and Catalent Pharma Solutions. Companies are leveraging automation, serialization, and smart packaging technologies such as NFC and QR to improve compliance, traceability, and user interaction. Early-stage collaboration with pharmaceutical developers and an emphasis on sustainable materials are helping contract packagers deliver customized, future-ready packaging solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing pharmaceutical industry
      • 3.2.1.2 Growing demand for biotechnology and specialty drugs
      • 3.2.1.3 Increase in clinical trials & small-batch packaging
      • 3.2.1.4 Increasing demand for sustainable packaging
      • 3.2.1.5 Increased focus on serialization & anti-counterfeiting
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High initial investment & operational costs
      • 3.2.2.2 Intense competition & price pressure
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates & Forecast, By Type, 2021-2034 (USD Billion)

  • 5.1 Key trends
  • 5.2 Primary packaging
    • 5.2.1 Bottles & jars
    • 5.2.2 Vials
    • 5.2.3 Ampoules
    • 5.2.4 Blister packs
    • 5.2.5 Prefilled syringes
    • 5.2.6 Others
  • 5.3 Secondary packaging
  • 5.4 Tertiary packaging

Chapter 6 Market Estimates & Forecast, By Material, 2021-2034 (USD Billion)

  • 6.1 Key trends
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper & paperboard
  • 6.5 Aluminium
  • 6.6 Others

Chapter 7 Market Estimates & Forecast, By Form Type, 2021-2034 (USD Billion)

  • 7.1 Key trends
  • 7.2 Oral
  • 7.3 Injectable
  • 7.4 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Billion)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Adare Pharma Solutions
  • 9.2 Amcor
  • 9.3 Ameripac
  • 9.4 Baxter Biopharma Solutions
  • 9.5 Catalent Pharma Solutions
  • 9.6 Daito Pharmaceutical
  • 9.7 Gracure Pharmaceutical
  • 9.8 MJS Packaging
  • 9.9 Nipro
  • 9.10 Patheon
  • 9.11 Pharma Packaging Solutions
  • 9.12 Schott
  • 9.13 Sharp
  • 9.14 Sonic Packaging Industries
  • 9.15 West Pharmaceutical Services
  • 9.16 WestRock
  • 9.17 Zoic Biotech